Literature DB >> 22728573

Preeclampsia and cardiovascular risk.

W Hermes1, F Van Kesteren, C J M De Groot.   

Abstract

The association between preeclampsia and cardiovascular disease has been an increasing area of interest over the last years. Cardiovascular disease is the number one cause of death in women in the western world and more women than men die of heart disease each year. The most common pregnancy disorder is preeclampsia. Preeclampsia is defined by hypertension and de novo proteinuria and remains responsible for high maternal and fetal morbidity and mortality worldwide. Pregnancy has been described as a "stress test" for future cardiovascular disease, to identify women young enough to benefit from screening. Women with a history of early onset (severe) preeclampsia have the highest risk of cardiovascular disease later. However, the exact underlying link between the two disorders is still unknown. In this review we describe different facets of the association between preeclampsia and cardiovascular disease and we give an overview of the recent literature.

Entities:  

Mesh:

Year:  2012        PMID: 22728573

Source DB:  PubMed          Journal:  Minerva Ginecol        ISSN: 0026-4784


  11 in total

1.  The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.

Authors:  M Cheng; P He; J Fu
Journal:  J Hum Hypertens       Date:  2016-05-12       Impact factor: 3.012

2.  Intraabdominal fat, insulin sensitivity, and cardiovascular risk factors in postpartum women with a history of preeclampsia.

Authors:  Darcy R Barry; Kristina M Utzschneider; Jenny Tong; Kersten Gaba; Daniel F Leotta; John D Brunzell; Thomas R Easterling
Journal:  Am J Obstet Gynecol       Date:  2015-05-21       Impact factor: 8.661

3.  Comparison of Hemodynamic and Biochemical Factors and Pregnancy Complications in Women with/without Preeclampsia.

Authors:  Banafsheh Mashak; Ramesh Baradaran Bagheri; Ghazal Noorani; Safoora Soleimanifakhr; Mina Ataei
Journal:  Maedica (Bucur)       Date:  2022-06

4.  Evaluation of CD39, CD73, HIF-1α, and their related miRNAs expression in decidua of preeclampsia cases compared to healthy pregnant women.

Authors:  Yousef Yousefzadeh; Mohammad Sadegh Soltani-Zangbar; Ladan Kalafi; Ali Tarbiat; Sima Shahmohammadi Farid; Leili Aghebati-Maleki; Forough Parhizkar; Shahla Danaii; Simin Taghavi; Farhad Jadidi-Niaragh; Hossein Samadi Kafil; Ata Mahmoodpoor; Javad Ahmadian Heris; Mohammad Hojjat-Farsangi; Mehdi Yousefi
Journal:  Mol Biol Rep       Date:  2022-09-01       Impact factor: 2.742

5.  Maternal plasma soluble TRAIL is decreased in preeclampsia.

Authors:  Piya Chaemsaithong; Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Tamara Stampalija; Nandor Gabor Than; Zhong Dong; Jezid Miranda; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-13

6.  Future cardiovascular risk: Interpreting the importance of increased blood pressure during pregnancy.

Authors:  Suttira Intapad; Barbara T Alexander
Journal:  Circulation       Date:  2013-02-12       Impact factor: 29.690

7.  The Norwegian preeclampsia family cohort study: a new resource for investigating genetic aspects and heritability of preeclampsia and related phenotypes.

Authors:  Linda Tømmerdal Roten; Liv Cecilie Vestrheim Thomsen; Astrid Solberg Gundersen; Mona Høysæter Fenstad; Maria Lisa Odland; Kristin Melheim Strand; Per Solberg; Christian Tappert; Elisabeth Araya; Gunhild Bærheim; Ingvill Lyslo; Kjersti Tollaksen; Line Bjørge; Rigmor Austgulen
Journal:  BMC Pregnancy Childbirth       Date:  2015-12-01       Impact factor: 3.007

8.  Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats.

Authors:  Hannah L Morgan; Elaine Butler; Shona Ritchie; Florian Herse; Ralf Dechend; Elisabeth Beattie; Martin W McBride; Delyth Graham
Journal:  Hypertension       Date:  2018-05-29       Impact factor: 10.190

9.  Apoptotic and stress signaling markers are augmented in preeclamptic placenta and umbilical cord.

Authors:  Syeda H Afroze; Ram R Kalagiri; Michelle Reyes; Jacqueline D Zimmerman; Madhava R Beeram; Nathan Drever; David C Zawieja; Thomas J Kuehl; Mohammad N Uddin
Journal:  BBA Clin       Date:  2016-05-25

Review 10.  Preventing cardiovascular disease after hypertensive disorders of pregnancy: Searching for the how and when.

Authors:  T Katrien J Groenhof; Bas B van Rijn; Arie Franx; Jeanine E Roeters van Lennep; Michiel L Bots; A Titia Lely
Journal:  Eur J Prev Cardiol       Date:  2017-09-12       Impact factor: 7.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.